Alterome Therapeutics Bags USD 132 Million in Series B Financing
Alterome Therapeutics, Inc. has announced the closing of a USD 132 million Series B financing.
Oncogenic | 05/04/2024 | By Aishwarya | 523
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy